Engur-Ozturk, S. And DİKMEN, M. 2022. Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages. MOLECULAR BIOLOGY REPORTS , vol.49, no.6 , 4777-4793.

Engur-Ozturk, S., & DİKMEN, M., (2022). Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages. MOLECULAR BIOLOGY REPORTS , vol.49, no.6, 4777-4793.

Engur-Ozturk, Selin, And MİRİŞ DİKMEN. "Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages," MOLECULAR BIOLOGY REPORTS , vol.49, no.6, 4777-4793, 2022

Engur-Ozturk, Selin And DİKMEN, MİRİŞ. "Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages." MOLECULAR BIOLOGY REPORTS , vol.49, no.6, pp.4777-4793, 2022

Engur-Ozturk, S. And DİKMEN, M. (2022) . "Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages." MOLECULAR BIOLOGY REPORTS , vol.49, no.6, pp.4777-4793.

@article{article, author={Selin Engur-Ozturk And author={MİRİŞ DİKMEN}, title={Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages}, journal={MOLECULAR BIOLOGY REPORTS}, year=2022, pages={4777-4793} }